×

Become an Incathlab member and receive full access to its content!

You must be an Incathlab member to access videos without any restrictions. Register for free in one minute and access all services provided by Incathlab.You will also be able to log into Incathlab from your Facebook or twitter account by clicking on login on the top-right corner of Incathlab website.

Registration Login


Description
Date : May 2016
Honolulu : Wednesday, May 11th 2016 from 04am to 06am (GMT-10)
San Francisco : Wednesday, May 11th 2016 from 07am to 09am (GMT-7)
New York : Wednesday, May 11th 2016 from 10am to 12pm (GMT-4)
Buenos Aires : Wednesday, May 11th 2016 from 11am to 01pm (GMT-3)
Reykjavik : Wednesday, May 11th 2016 from 02pm to 04pm (GMT)
London / Dublin : Wednesday, May 11th 2016 from 03pm to 05pm (GMT+1)
Paris / Berlin : Wednesday, May 11th 2016 from 04pm to 06pm (GMT+2)
Istanbul : Wednesday, May 11th 2016 from 05pm to 07pm (GMT+3)
Moscou / Dubaï : Wednesday, May 11th 2016 from 06pm to 08pm (GMT+4)
Bangkok : Wednesday, May 11th 2016 from 09pm to 11pm (GMT+7)
Shanghai : Wednesday, May 11th 2016 from 10pm to 12am (GMT+8)
Tokyo : Wednesday, May 11th 2016 from 11pm to 01am (GMT+9)
Sydney : Thursday, May 12th 2016 from 01am to 03am (GMT+11)
Wellington : Thursday, May 12th 2016 from 03am to 05am (GMT+13)
Last update : 2016-09-27
Language(s) : English
Views : 17386

In the last twenty years, endovascular technology has revolutionized the management of patients with abdominal aortic aneurysm (AAA) because of its less invasiveness.

Endovascular stent grafting is a newer form of treatment for Abdominal Aortic Aneurysm that is less invasive than open surgery. Endovascular stent grafting uses an endovascular stent graft to reinforce the wall of the aorta and to help keep the damaged area from rupturing.

The technology has evolved from large profile endoprothesis but requires open-surgery to low profile endoprothesis implantable percutaneously (PEVAR).

Furthermore, the development of different type of endoprothesis and extension has allowed the treatment of more complex abdominal aorta aneurysm. This second websymposium describes the latest low profile endovascular prothesis and its use by our Italian colleagues.

 

Program (GMT +2) 

16:00 Introduction - Prof. Ippoliti
16:10 1st Live Procedure - Dr Pratesi / Dr Barbante
16:45 The role of low profile AAA stent grafts in expanding EVAR feasibility - Dr Pratesi
16:55 2nd Live case - Dr Pratesi / Dr Barbante
17:30 What data exists to support the daily use of low profile AAA stent grafts - Dr Pratesi
17:40 Q&A. Final Discussion and Debate - Prof. Ippoliti / Dr Pratesi
18:00 End of the Webinar

Educational objectives

  • Discuss current use of low profile AAA stent grafts with percutaneous access and closure
  • Selection of sizes and extensions of this new endovascular graft
  • Provide platform for discussion of the patients’ outcomes and population treated with low profile AAA stent grafts
  • Demonstrate advanced techniques in the treatment of aortic disease
  • Demonstrate new tools available
  • Provide platform for discussion and mutual learning

Targeted audience

  • Endovascular specialists (Vascular Surgeons, Interventional Radiologists, Interventional Angiologists and Interventional Cardiologists)
  • Referring physicians of patients with vascular disease(s)



IMPORTANT NOTICE

This webinar is an educational event supported by Cordis Corporation, and is intended for Healthcare Professionals in Europe Middle East and Africa. 

The use of the INCRAFT® AAA Stent-Graft System requires that physicians be specially trained in endovascular abdominal aortic aneurysm repair techniques, including experience with high resolution fluoroscopy and radiation safety. Cordis Corporation will provide training specific to the INCRAFT® AAA Stent-Graft System.

The INCRAFT® System is currently approved for investigational device use only in the U.S. and Japan and is being studied in a global pivotal clinical study in the U.S. and Japan called the INSPIRATION Trial, which completed enrollment in 2013.’

While every effort is made to see that no inaccurate or misleading data, opinions, or statements appear in this webinar, Cordis Corporation wish to make it clear that material contained in the webinar represents independent evaluations and opinions of the authors and contributors. As a consequence, Cordis Corporation accepts no responsibility for the consequences of any such inaccurate or misleading data or statements. Neither do they endorse the content or the use of any drug or medical device in a way that lies outside its current licensed application in any territory. This presentation may include the demonstration of the use of medical devices; it is not intended to be used as a training guide. The steps demonstrated may not be the complete steps of the procedure. Individual preference and experience, as well as patient needs, may dictate variation in procedure steps. Before using any medical device, including those demonstrated or referenced in this webinar, review all relevant package inserts, with particular attention to the indications, contraindications, warnings and precautions, and steps for use of the device.

All content in these presentations is owned by their authors and is protected by worldwide copyright laws. No modification or further reproduction of the content is permitted. 

Prof. Ippoliti, Dr. Pratesi and Dr. Barbante are compensated by and presenting on behalf of Cordis.


©2016 Cardinal Health.  All Rights Reserved.
CORDIS, the Cordis LOGO, INCRAFT are trademark or registered trademarks of Cardinal Health.

EU868 5/16

Comments(1)
Join the Discussion
  • Manuel Alonso A. Great session. Congratulations for contribution

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    Comment with Facebook

    Thursday, February 28th 2019 from 11:30am to 01pm (GMT+2)
    Honolulu : Wednesday, February 27th 2019 from 11:30pm to 01am (GMT-10)
    San Francisco : Thursday, February 28th 2019 from 01:30am to 03am (GMT-8)
    New York : Thursday, February 28th 2019 from 04:30am to 06am (GMT-5)
    Buenos Aires : Thursday, February 28th 2019 from 06:30am to 08am (GMT-3)
    London / Dublin : Thursday, February 28th 2019 from 09:30am to 11am (GMT)
    Paris / Berlin : Thursday, February 28th 2019 from 10:30am to 12pm (GMT+1)
    Istanbul : Thursday, February 28th 2019 from 11:30am to 01pm (GMT+2)
    Moscou / Dubaï : Thursday, February 28th 2019 from 01:30pm to 03pm (GMT+4)
    Bangkok : Thursday, February 28th 2019 from 04:30pm to 06pm (GMT+7)
    Shanghai : Thursday, February 28th 2019 from 05:30pm to 07pm (GMT+8)
    Tokyo : Thursday, February 28th 2019 from 06:30pm to 08pm (GMT+9)
    Sydney : Thursday, February 28th 2019 from 07:30pm to 09pm (GMT+10)
    Wellington : Thursday, February 28th 2019 from 09:30pm to 11pm (GMT+12)

    Introducing innovative solutions for the treatment of visceral arteries in complex BEVAR and FEVAR

    Best clinical practice for achieving perfusion of visceral arteries

    Share
    December 2016
    Honolulu : Thursday, December 8th 2016 from 04am to 06am (GMT-10)
    San Francisco : Thursday, December 8th 2016 from 06am to 08am (GMT-8)
    New York : Thursday, December 8th 2016 from 09am to 11am (GMT-5)
    Buenos Aires : Thursday, December 8th 2016 from 11am to 01pm (GMT-3)
    London / Dublin : Thursday, December 8th 2016 from 02pm to 04pm (GMT)
    Paris / Berlin : Thursday, December 8th 2016 from 03pm to 05pm (GMT+1)
    Istanbul : Thursday, December 8th 2016 from 04pm to 06pm (GMT+2)
    Moscou / Dubaï : Thursday, December 8th 2016 from 06pm to 08pm (GMT+4)
    Bangkok : Thursday, December 8th 2016 from 09pm to 11pm (GMT+7)
    Shanghai : Thursday, December 8th 2016 from 10pm to 12am (GMT+8)
    Tokyo : Thursday, December 8th 2016 from 11pm to 01am (GMT+9)
    Sydney : Friday, December 9th 2016 from 12am to 02am (GMT+10)
    Wellington : Friday, December 9th 2016 from 02am to 04am (GMT+12)

    Low profile AAA stent grafts in PEVAR

    Benefits, Durability and long-term Data

    Share
    Scroll Up